Transderm scop and Thirst - a phase IV clinical study of FDA data

Summary:

Thirst is reported only by a few people who take Transderm Scop.

The phase IV clinical study analyzes which people take Transderm scop and have Thirst. It is created by eHealthMe based on reports of 2,756 people who have side effects while taking Transderm scop from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 22, 2022

2,756 people reported to have side effects when taking Transderm scop.
Among them, 5 people (0.18%) have Thirst.


What is Transderm scop?

Transderm scop has active ingredients of scopolamine. It is often used in motion sickness. eHealthMe is studying from 2,817 Transderm scop users for its effectiveness, alternative drugs and more.

What is Thirst?

Thirst is found to be associated with 1,884 drugs and 1,286 conditions by eHealthMe.

Number of Transderm scop and Thirst reports submitted per year:

Could Transderm scop cause Thirst?

Time on Transderm scop when people have Thirst *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Thirst when taking Transderm scop *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Thirst when taking Transderm scop *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 50 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 50 %

Common drugs people take besides Transderm scop *:

  1. Zyrtec: 2 people, 40.00%
  2. Zofran: 2 people, 40.00%
  3. Butrans: 2 people, 40.00%
  4. Bystolic: 2 people, 40.00%
  5. Cymbalta: 2 people, 40.00%
  6. Dilaudid: 2 people, 40.00%
  7. Frova: 2 people, 40.00%
  8. Glucosamine: 2 people, 40.00%
  9. Lamictal: 2 people, 40.00%
  10. Lotemax: 2 people, 40.00%

Common side effects people have besides Thirst *:

  1. Headache (pain in head): 2 people, 40.00%
  2. Cerebrospinal Fluid Leakage: 2 people, 40.00%
  3. Postural Orthostatic Tachycardia Syndrome (abnormal increase in heart rate on becoming upright): 2 people, 40.00%
  4. Neuropathy Peripheral (surface nerve damage): 2 people, 40.00%
  5. Hypovolaemia (a decreased volume of circulating blood in the body): 2 people, 40.00%
  6. Hospitalisation: 2 people, 40.00%
  7. Heart Rate Increased: 2 people, 40.00%
  8. Feeling Hot: 1 person, 20.00%
  9. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 1 person, 20.00%
  10. Confusional State: 1 person, 20.00%

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 40.00%

* Approximation only. Some reports may have incomplete information.

Do you take Transderm scop and have Thirst?

Check whether Thirst is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Thirst and when was it recovered:

Expand to all the drugs that have ingredients of scopolamine:

Alternative drugs to, pros and cons of Transderm scop:

Common Transderm scop side effects:

Browse all side effects of Transderm scop:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Thirst treatments and more:

COVID vaccines that are related to Thirst:

Common drugs associated with Thirst:

All the drugs that are associated with Thirst:

Common conditions associated with Thirst:

All the conditions that are associated with Thirst:

How the study uses the data?

The study uses data from the FDA. It is based on scopolamine (the active ingredients of Transderm scop) and Transderm scop (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: